Effects of thiol chelation on α1-adrenoceptor-induced vasoconstriction in vivo

Journal of Cardiovascular Pharmacology

Volumn 46, Issue 5, 2005, Pages 627-636

  Hoque, Azizul ^a   Owen, Joy R ^b   Bates, James N ^c   Lewis, Stephen J ^b  

^a UNIVERSITY OF LOUISVILLE   (United States)

^b UNIVERSITY OF GEORGIA   (United States)

^c UNIVERSITY OF IOWA   (United States)

Author keywords

1 adrenoceptors; Hemodynamics; Rats; Thiol residues

Indexed keywords

ALPHA 1 ADRENERGIC RECEPTOR; ALPHA 1 ADRENERGIC RECEPTOR STIMULATING AGENT; CALCIUM CHANNEL; CALCIUM CHANNEL BLOCKING AGENT; CALCIUM ION; HYDROXYMERCURIBENZOIC ACID; NIFEDIPINE; NITRIC OXIDE DONOR; NITROPRUSSIDE SODIUM; NORADRENALIN; PHENYLEPHRINE; THIOL DERIVATIVE; URETHAN;

ANIMAL CELL; ANIMAL TISSUE; ARTICLE; CALCIUM CELL LEVEL; CALCIUM MOBILIZATION; CHELATION; CONTROLLED STUDY; IN VIVO STUDY; MALE; MEAN ARTERIAL PRESSURE; NONHUMAN; PRIORITY JOURNAL; RAT; RECEPTOR UPREGULATION; VASCULAR RESISTANCE; VASCULAR SMOOTH MUSCLE; VASOCONSTRICTION; VASODILATATION; VOLTAGE CLAMP;

ADRENERGIC ALPHA-AGONISTS; ANIMALS; DOSE-RESPONSE RELATIONSHIP, DRUG; HYDROXYMERCURIBENZOATES; MALE; NIFEDIPINE; NOREPINEPHRINE; PHENYLEPHRINE; RATS; RATS, SPRAGUE-DAWLEY; RECEPTORS, ADRENERGIC, ALPHA-1; SULFHYDRYL REAGENTS; VASOCONSTRICTION; VASODILATOR AGENTS;

EID: 27344449313     PISSN: 01602446     EISSN: None     Source Type: Journal    
DOI: 10.1097/01.fjc.0000181718.25323.91     Document Type: Article

References (49)

1. Probst WC, Snyder LA, Schuster DI, et al. Sequence alignment of the G-protein coupled receptor superfamily. DNA Cell Biol. 1992;11:1-20.
2. 1- Adrenoceptor classification: sharpening Occam's razor. Trends Pharmacol Sci. 1994; 15:167-170.
3. 1D subtype. Eur J Pharmacol. 1996;297:241-248.
4. 2+ in smooth muscle. Nature. 1987;329:333-335.
5. 1- adrenoceptors in vascular smooth muscle. Mol Pharmacol. 1994;46:30-40.
6. 1- adrenoceptor sub-types in rat aorta by solution hybridization. Life Sci. 1996;59:343-347.
7. 1-adrenoceptor mediating vasoconstriction in perfused rat hindlimb. Eur J Pharmacol. 1997;329:55-61.
8. 1 adrenoceptor (AR) subtypes in the isolated rat mesenteric vascular bed [abstract]. FASEB J. 1994;8:A874.
9. 1- adrenoceptors mediating vasoconstriction to noradrenaline and nerve stimulation in the isolated perfused mesentery of the rat. Br J Pharmacol. 1995;114:531-536.
10. 1A-adrenoceptors. Eur J Pharmacol. 1991;202:33-44.
11. 1C- adrenoceptor: studies in the isolated perfused kidney of the rat. Br J Pharmacol. 1995;115:283-294.
12. Radi R, Beckman JS, Bush KM, et al. Pcroxynitrite oxidation of sulfhydryls: the cytotoxic potential of superoxide and nitric oxide. J Biol Chem. 1991;266:4244-4250.
13. Radi R, Beckman JS, Bush KM, et al. Peroxynitrite-induced membrane lipid peroxidation: the cytotoxic potential of superoxide and nitric oxide. Arch Biochem Biophys. 1991;288:481-487.
14. Benkusky NA, Lewis SJ, Kooy NW. Peroxynitrite-mediated attenuation of α- and β-adrenoceptor agonist-induced vascular responses in vivo. Eur J Pharmacol. 1999;364:151-158.
15. Beckman JS, Ye YZ, Anderson P, et al. Extensive nitration of protein tyrosines in human atherosclerosis detected by immunohistochemistry. Biol Chem Hoppe Seyler. 1994;375:81-88.
16. Kooy NW, Lewis SJ, Royall JA, et al. Extensive tyrosine nitration in human myocardial inflammation: evidence for the presence of peroxynitrite. Crit Care Med. 1997;25:812-819.
17. Goodman I, Hiatt RB. Chemical factors affecting spontaneous motility of the small intestine in the rat. 1. Sulphydryl reactants. Biochem Pharmacol. 1964;13:871-879.
18. Abdel-Latif AA. Calcium-mobilizing receptors, polyphosphoinositols, and the generation of second messengers. Pharmacol Rev. 1986;38:227-272.
19. Satake N, Kiyoto S, Shibata S, et al. Possible mechanisms of inhibition with atropine against noradrenaline-induced contraction in the rabbit aorta. Br J Pharmacol 1992;107:553-558.
20. Lamb FS, Barna TJ. Chloride ion currents contribute functionally to norepinephrine-induced vascular contraction. Am J Physiol. 1998;275: H151-H160.
21. Lamb FS, Barna TJ. The endothelium modulates the contribution of chloride currents to norepinephrine-induced vascular contraction. Am J Physiol. 1998;275:H161-H168.
22. Lamb FS, Kooy NW, Lewis SJ. Role of CT-channels in α-adrenoceptor- mediated vasoconstriction in the anesthetized rat. Eur J Pharmacol. 2000; 401:403-412.
23. 3 receptor subtypes. Brain Res. 1991;561:61-68.
24. Zifa E, Fillion G. 5-Hydroxytryptamine receptors. Pharmacol Rev. 1992; 44:401-458.
25. Julius D. Molecular biology of serotonin receptors. Annu Rev Neurosci. 1991;14:335-360.
26. Hollenberg NK. Serotonin and vascular responses. Annu Rev Pharmacol Toxicol. 1988;28:41-59.
27. Campbell DL, Stamler JS, Strauss HC. Redox modulation of L-type calcium channels in ferret ventricular myocytes: dual actions of nitric oxide and S-nitrosothiols. J Gen Physiol 1996;108:277-293.
28. Davisson RL, Bates JN, Johnson AK, et al. Use-dependent loss of acetylcholine- and bradykinin-mediated after nitric oxide synthase inhibition: Evidence for preformed stores of nitric oxide-containing factors in vascular endothelial cells. Hypertension. 1996;28:354-360.
29. Davisson RL, Shaffer RA, Johnson AK, et al. Use-dependent loss of active sympathetic neurogenic vasodilation following nitric oxide synthase inhibition in conscious rats: evidence for the presence of preformed stores of nitric oxide-containing factors. Hypertension. 1996; 28:347-353.
30. Davisson RL, Shaffer RA, Johnson AK, et al. Stimulation of lumbar sympathetic nerves may produce hindlimb vasodilation via the release of pre-formed stores of nitrosyl factors. Neuroscience. 1996;72:881-887.
31. Davisson RL, Travis MD, Bates JN, et al. Hemodynamic effects of L- and D-S-nitrosocysteine in the rat: stereoselective S-nitrosothiol recognition sites. Circ Res. 1996;79:256-262.
32. Davisson RL, Possas OS, Murphy SP, et al. Neurogenically derived nitrosyl factors mediate lumbar sympathetic vasodilation in the hindlimb vasculature of the rat. Am J Physiol. 1997;272:H2369-H2376.
33. Davisson RL, Travis MD, Bates JN, et al. Stereoselective actions of S-nitrosocysteine in the central nervous system of conscious rats. Am J Physiol 1997;272:H2361-H2368.
34. Davisson RL, Walton TM, Johnson AK, et al. Cardiovascular effects produced by systemic injections of nitro blue tetrazolium (NBT) in the rat. Eur J Pharmacol. 1993;241:135-137.
35. 3 receptors on vagal afferents mediating the Bezold-Jarisch reflex. Brain Res. 2000;873:302-305.
36. Haywood JR, Shaffer RA, Fastenow C, et al. Regional blood flow measurement with pulsed Doppler flowmeter in conscious rat. Am J Physiol 1981;241:H273-H278.
37. Feelisch M. The biochemical pathways of nitric oxide formation from nitrovasodilators: appropriate choice of exogenous NO donors and aspects of preparation and handling of aqueous NO solutions. J Cardiovasc Pharmacol. 1991;17(suppl 3):25-33.
38. 2+-channels markedly diminishes nitric oxide- but not L-S-nitrosocysteine- or endothelium-dependent vasodilation in vivo. Eur J Pharmacol. 2000; 408:289-298.
39. Winer BJ. Statistical Principles of Experimental Design. New York, NY: McGraw Hill; 1971:752-809.
40. Wallenstein S, Zucker C, Fleiss JL. Some statistical methods useful in circulation research. Circ Res. 1980;47:1-9.
41. Moncada S, Palmer RMJ, Higgs EA. Nitric oxide; physiology, pathophysiology and pharmacology. Pharmacol Rev. 1991;43:109-142.
42. Stamler JS, Singel DJ, Loscalzo J. Biochemistry of nitric oxide and its redox-activated forms. Science. 1992;258:1898-1902.
43. Stamler JS. Redox signaling: nitrosylation and related target interactions of nitric oxide. Cell. 1994;78:931-936.
44. Stamler JS, Toone EJ, Lipton SA, et al. (S)NO signals: translocation, regulation, and a consensus motif. Neuron. 1997;18:691-696.
45. Myers PR, Minor R Jr, Guerra R Jr, et al. Vasorelaxant properties of the endothelium-derived relaxing factor more closely resembles S-nitrosocysteine than nitric oxide. Nature. 1990;345:161-163.
46. Rosenblum WI. Endothelium-derived relaxing factor in brain blood vessels is not nitric oxide. Stroke. 1992;23:1527-1535.
47. Hoque A, Bates JN, Lewis SJ. In vivo evidence that L-S-nitrosocysteine may exert its vasodilator effects by interaction with thiol residues in the vasculature. Eur J Pharmacol. 1999;384:169-172.
48. Whalen EJ, Johnson AK, Lewis SJ. β-Adrenoceptor dysfunction after inhibition of NO synthesis. Hypertension. 2000;36:376-382.
49. Hoque A, Bates JN, Lewis SJ. Redox regulation of S-nitrosocysteine- mediated vasodilation in vivo. Eur J Pharmacol. 2000;408:195-198.